Dr Sion Scott

Lecturer in Behavioural Medicine

School/Department: Healthcare, School of



I am one of few hospital pharmacist researchers and my expertise is applying behavioural science with qualitative and co-design methods to address medicines optimisation challenges. Qualitative methods provide me with a rich understanding of the barriers and enablers to the desired behaviour. Behavioural science enables me to draw out the behavioural mechanisms of action that can be targeted by interventions. My expertise in co-design methodologies enables me to then work with target audience(s) to design theory and evidence-based interventions.


Current research projects

Previous research projects

  • Generating the evidence for safely and acceptably switching people with Parkinson’s to liquid formulations (Chief investigator) - EIRA Research and Development Grant (2020-2021)
  • Selecting theory and evidence-based components and characterising their modes of delivery for a hospital deprescribing intervention - (Chief investigator) - Pharmacy Research UK (2018-2019)
  • Developing a theory and evidence-based model for hospital deprescribing - (Chief investigator) - Pharmacy Research UK (2017-2018)



Smith C, Bhattacharya D, Scott S. Understanding how primary care practitioners can be supported to recognise, screen and initially diagnose oropharyngeal dysphagia: Protocol for a behavioural science realist review. BMJ open (accepted in press)

Alharthi M, Wright D, Scott S, Birt L. Barriers and enablers to deprescribing for older people in care homes: the theory-based perspectives of pharmacist independent prescribers. Research in Social and Administrative Pharmacy (accepted in press)

Good E, Bhattacharya D, Scott S. What is known about the determinants of developing antipsychotic-induced metabolic syndrome and interventions to address them for community dwelling adults: a scoping review protocol. medRxiv 2023.01.05.22283663; doi:

Micallef C, Enoch DA, Kamranpour P, Santos R, Tyler N, Scott S. The role of hospital antimicrobial and infectious diseases pharmacists in the UK: a theoretically underpinned exploration. JAC-Antimicrobial Resistance. 2023 Feb;5(1):dlac136.

Alharthi M, Scott S, Alldred DP, Holland R, Hughes C, Birt L, Blacklock J, Bond C, Clark A, Wright D. Pharmacist Independent Prescriber (PIP) deprescribing in UK care homes: contextual factors associated with increased activity. British Journal of Clinical Pharmacology. 2022 Dec 14.

Birt L, Wright DJ, Blacklock J, Bond CM, Hughes CM, Alldred DP, Holland R, Scott S. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes. Health & Social Care in the Community. 2022 Nov;30(6):e6521-31.

Patel A, Sims E, Blacklock J, Birt L, Bion V, Clark A, S Scott et al. Cluster randomised control trial protocol for estimating the effectiveness and cost-effectiveness of a complex intervention to increase care home staff influenza vaccination rates compared to usual practice (FLUCARE). Trials. 2022 Dec;23(1):1-2.

Greene, L., Aryankhesal, A., Megson, M., Blake, J., Wong, G., Briscoe, S., Hilton, A., Killett, A., Reeve, J., Allan, L., Ballard, C., Broomfield, N., van Horik, J., Khondoker, M., Lazar, A., Litherland, R., Livingston, G., Maidement, I., Medina-Lara, A., Rook, G., Scott, S., Shepstone, L. and Fox, C. Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocol. BMJ open. 2022 Nov 1;12(11):e067424.

Wade Thompson, Chris Xi, Carmel Hughes, Frank Moriarty, Douglas M Salzwedel, Emily McDonald, Jennifer Pruskowski, Adam Bleik, Harman Waring, Sion Scott, Anne Spinewine, Jean S Kutner, Emma Bjørk, Trine Graabæk Hansen, Carina Lundby. Measuring quality of life in deprescribing trials: a scoping review protocol. 2022

Alharthi M, Wright D, Scott S, Blacklock J. Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review. International Journal of Clinical Pharmacy. 2022 Nov 21:1-6.

Rendell T, Barnett J, Scott S, Wright D. Designing an evidence based community pharmacy service specification for a pharmacogenomic testing service. International Journal of Clinical Pharmacy. 2022 Dec;44(6):1406-16.

Martin-Kerry J, Taylor J, Scott S, Patel M, Wright D, Clark A, Turner D, Alldred DP, Murphy K, Keevil V, Witham MD. Developing a core outcome set for hospital deprescribing trials for older people under the care of a geriatrician. Age and Ageing. 2022 Nov;51(11):afac241.

Atkins, B, Bhattacharya, D, Smith, C, S Scott. Barriers and enablers to switching from a solid to a liquid formulation of Parkinson’s medication: a theory-based mixed methods investigation. Int J Clin Pharm 44, 1046–1056 (2022).

Rendell T, Barnett J, Scott S, Wright D. Designing a theory and evidence informed pharmacogenomic testing service in community pharmacy in England. Research in Social and Administrative Pharmacy. 2022 Apr 9.

Scott S. Deprescribing: a call for research that supports implementation in practice. International Journal of Pharmacy Practice. 2021 Dec;29(6):525-6.

Prajapati AR, Dima A, Mosa G, Scott S, Song F, Wilson J, Bhattacharya D. Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review. Psychological medicine. 2021 May.

Hatton K, Bhattacharya D, Scott S, Wright D. Barriers and facilitators to pharmacists integrating into the ward-based multidisciplinary team: A systematic review and meta-synthesis. Research in Social and Administrative Pharmacy. 2021 Nov 1;17(11):1923-36.

Scott S, Wright DJ, Bhattacharya D. The role of behavioural science in changing deprescribing practice. British journal of clinical pharmacology. 2021;87(1):39-41.

Scott S, May H, Patel M, Wright DJ, Bhattacharya D. A practitioner behaviour change intervention for deprescribing in the hospital setting. Age and ageing. 2021 Mar;50(2):581-6.

Scott S, Twigg MJ, Clark A, Farrow C, May H, Patel M, Taylor J, Wright DJ, Bhattacharya D. Development of a hospital deprescribing implementation framework: a focus group study with geriatricians and pharmacists. Age and ageing. 2020 Jan 1;49(1):102-10.

Shenoy R, Scott S, Bhattacharya D. Quantifying and characterising multi-compartment compliance aid provision. Research in Social and Administrative Pharmacy. 2020 Apr 1;16(4):560-7.

Scott S, Clark A, Farrow C, May H, Patel M, Twigg MJ, Wright DJ, Bhattacharya D. Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital. BMC geriatrics. 2019 Dec;19(1):1-1.

Prajapati AR, Dima AL, Clark AB, Gant C, Gibbons C, Gorrod R, Mosa G, Scott S, Song F, Teague B, Twigg MJ. Mapping of modifiable barriers and facilitators of medication adherence in bipolar disorder to the Theoretical Domains Framework: a systematic review protocol. BMJ open. 2019 Jun 1;9(2):e026980.Wright D,

Wright DJ, Scott S, Bhattacharya D. Deprescribing: routine pharmacy practice or an exciting research opportunity?. International Journal of Pharmacy Practice. 2019 Oct;27(5):406-7.

Wright D, Scott S, Buck J, Bhattacharya D. Role of nurses in supporting proactive deprescribing. Nursing Standard. 2019 Feb 22;34(3):44-50.

Scott S, Clark A, May H, Bhattacharya D. Validation and feasibility of the medication acceptability questionnaire to investigate tablet and liquid alendronic acid with older hospital patients. Pharmacy. 2018 Aug 11;6(3):84.

Scott S, Clark A, Farrow C, May H, Patel M, Twigg MJ, Wright DJ, Bhattacharya D. Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. International journal of clinical pharmacy. 2018 Oct;40(5):991-6.

Al-Jabr H, Twigg MJ, Scott S, Desborough JA. Patient feedback questionnaires to enhance consultation skills of healthcare professionals: a systematic review. Patient Education and Counseling. 2018 Sep 1;101(9):1538-48.



I am happy to supervise PhD projects with a behavioural science methodological approach underpinning the development and evaluation of healthcare innovations. Please email me if you would like to discuss a potential PhD project.

Current PhD students



Emma Good
Development of a behaviour change intervention to prevent severe antipsychotic medication associated metabolic syndrome (University of Leicester PhD studentship) (2022-25)


Caroline Smith
Development of a behaviour change intervention for screening and management of oropharyngeal dysphagia in primary care (University of Leicester PhD studentship) (2021-24)


MPharm (Hons) First class, University of East Anglia (2015)

PhD Behavioural medicine, University of East Anglia (2019)

PGCert Higher Education Practice, University of East Anglia (2020)

Back to top